Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy — Sanne de Haas (2014) | RDL Network
Diether Lambrechts, Bart Claes, Paul Delmar, Joke Reumers, Massimiliano Mazzone, Betül T. Yesilyurt, Roland Devlieger, Chris Verslype, Sabine Tejpar, Hans Wildiers, Sanne de Haas, Peter Carmeliet, Stefan Scherer, Eric Van Cutsem
Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean–Frédéric Blanc, Lünan Yan, Jijin Yang, Ligong Lu, Won Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi‐Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian Walters, Christine Dela Cruz, Valerie Poulart, Jianhua Wang
Smith Giri, Alyssa Grimshaw, Susan Bal, Kelly Godby, Prakash Kharel, Benjamin Djulbegović, Saad Z. Usmani, Thierry Façon, Philippe Moreau, Meletios A Dimopoulos, María‐Victoria Mateos, Luciano J. Costa
Discussion(0)
No comments yet. Be the first to comment.